Integer Holdings

Integer Holdings Corp. engages in the manufacture and development of medical devices and components. It operates through the Medical and Non-Medical segments. The Medical segment includes the cardio and vascular, cardiac and neuromodulation, surgical, orthopedics, and portable medical product lines. The Non-Medical segment comprises customized battery power and management systems, charging and docking stations, and power supplies. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Earnings data Q4 2025

Earnings data Q1 2026

Integer Holdings reports strong Q1 performance amidst growth challenges

Integer Holdings' Q1 2023 performance showcased robust sales growth and improved operating income, underpinned by recovery from delayed shipments and strong demand. The company faces challenges from supply chain disruptions and direct labor turnover but is focused on margin improvement and profit growth acceleration.
With a positive pricing environment and a pragmatic approach to challenges, Integer Holdings aims to leverage its strong product development sales and targeted organic growth to outperform the market. Managing financial pressures effectively will be crucial for sustaining growth investments and financial stability.
Overall, Integer Holdings' strategic focus on operational efficiency, market leadership through innovation, and long-term resilience positions it well to navigate challenges and capitalize on growth opportunities in the evolving healthcare industry.

Integer Holdings reports robust Q2 results and raises full-year outlook

Integer Holdings delivered strong Q2 results, showcasing robust sales growth and operational performance driven by customer demand and supply chain enhancements.
The company raised its full-year outlook, emphasizing strategic growth, margin expansion, and commitment to customer satisfaction, indicating confidence in sustained growth.
While facing challenges related to market dynamics and operational efficiency, Integer Holdings remains well-positioned to capitalize on opportunities for revenue growth and value creation.
By focusing on customer-centric strategies, operational excellence, and strategic initiatives, Integer Holdings aims to drive sustainable growth and profitability in the evolving market landscape.

Integer Holdings reports strong Q3 performance and eyes growth opportunities

Integer Holdings showcased robust financial performance in Q3, driven by strong organic sales growth and improved operating income.
While facing challenges in debt management and operational integration, the company remains well-positioned in key product lines and growth areas.
With a positive outlook for 2023 and beyond, Integer Holdings is strategically focused on capitalizing on growth opportunities and maintaining financial strength.

Integer Holdings reports strong 2023 performance and growth strategies

Integer Holdings is poised for continued growth in 2024, with a focus on acquisitions, margin expansion, and operational efficiency.
Challenges include tax-related impacts, customer inventory adjustments, and the CRM segment's growth trajectory.
Opportunities lie in strategic acquisitions, margin improvement initiatives, and the strong performance of the Neuromodulation segment.

Integer Holdings reports robust Q1 performance, eyes continued growth

Integer Holdings delivered strong financial performance in Q1 2024, with sales, operating income, and EPS showing significant growth. Despite challenges in meeting the initial profit growth target, the company remains optimistic about its growth prospects and aims to enhance shareholder value through strategic execution.

Integer Holdings excels in Q2, raises profit outlook for 2024

Integer Holdings delivered a strong Q2 performance with sales, operating income, and EPS showing significant growth. The company's financial health remains robust, with a positive outlook for the full year and opportunities for continued growth and profitability.

Integer Holdings excels in Q3, focuses on medical tech growth

Integer Holdings reported strong financial performance in Q3 2024, with notable sales and operating income growth. The company's strategic divestment, improved financial outlook, and focus on medical technology highlight a clear path for future success.

Integer Holdings reports robust Q4 performance and strategic acquisitions

Integer Holdings (ITGR) demonstrated strong financial performance in Q4 2024, with notable sales growth and improved profitability. The company's strategic actions of divestiture and acquisitions signal a focused approach to enhancing its market position and offerings. While facing challenges in a competitive landscape, Integer Holdings has opportunities to leverage its strengths and drive continued growth in 2025.

Integer Holdings reports strong Q2 earnings, eyes growth opportunities

Integer Holdings demonstrated solid financial performance in Q2 2025, with notable sales and earnings growth across key segments. Effective debt management and improved cash flow highlight the company's financial stability and operational efficiency. While facing challenges in certain sales segments, Integer Holdings remains optimistic about its full-year outlook and growth prospects. Strategic focus on shareholder value and market opportunities positions the company well for sustained success and future expansion.

Integer Holdings (ITGR) reports robust Q3 results amidst sales challenges

Integer Holdings (ITGR) delivered strong financial performance in Q3 2025 but faced challenges from customer updates impacting sales. Despite near-term uncertainties, management remains optimistic about returning to growth in 2027.

Integer Holdings (ITGR) reports robust earnings, eyes sustainable growth amidst challenges

Integer Holdings (ITGR) delivered strong financial performance in Q4 2025 and full year 2025, driven by sales growth and operational improvements. While facing challenges from new products, the company remains focused on its long-term growth strategy and operational efficiency.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Integer Holdings Corp. engages in the manufacture and development of medical devices and components. The firm has the following product lines: Cardio and Vascular, Cardiac Rhythm Management and Neuromodulation, and Other Markets. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.